Core Viewpoint - Tennant Company is under investigation for potential violations of federal securities laws related to misleading statements about its ERP system rollout, which led to significant operational disruptions and a substantial stock price drop [1][3][4]. Group 1: Investigation Details - Bleichmar Fonti & Auld LLP is investigating Tennant for possibly making false statements regarding the implementation of a large-scale ERP system, claiming it was "on time and on budget" while the reality was different [3]. - The investigation focuses on whether Tennant misled investors about the success of the ERP launch in the Asia-Pacific region and the overall stability of operations [3]. Group 2: Financial Impact - Following the ERP system rollout in North America, Tennant experienced severe operational disruptions, resulting in an estimated loss of $30 million in sales and an increased remediation cost of over $20 million for 2026, compared to the planned $5 million [3]. - The stock price of Tennant dropped by $19.28 per share, a decline of more than 23%, from $82.30 on February 23, 2026, to $63.02 on February 24, 2026 [4]. Group 3: Legal Options for Investors - Investors in Tennant are encouraged to seek legal options and can submit their information to BFA, which operates on a contingency fee basis, meaning no upfront costs for shareholders [5][6].

Core Viewpoint - Hub Group Inc. is under investigation for potential violations of federal securities laws related to misrepresentation of financial data, specifically concerning purchased transportation costs and accounts payable for the first nine months of 2025 [1][2]. Group 1: Investigation Details - Bleichmar Fonti & Auld LLP is leading the investigation into Hub Group for possible misrepresentation of financial information [1]. - The investigation focuses on whether Hub Group inaccurately reported its purchased transportation costs and accounts payable [2]. Group 2: Stock Performance - Hub Group announced a delay in releasing its fourth quarter and full year 2025 financial results on February 5, 2026, due to an error that understated purchased transportation costs and accounts payable [3]. - Following this announcement, Hub Group's stock price dropped over 24% during trading on February 6, 2026 [4].

Core Viewpoint - A class action lawsuit has been filed against Plug Power Inc. and its senior executives for securities fraud, following significant stock drops attributed to potential violations of federal securities laws [1][4]. Group 1: Lawsuit Details - Investors have until April 3, 2026, to request to lead the case, which is pending in the U.S. District Court for the Northern District of New York [4][10]. - The lawsuit claims violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of Plug Power investors [4][10]. Group 2: Allegations Against Plug Power - Plug Power is accused of materially overstating the likelihood of receiving a $1.66 billion loan guarantee from the U.S. Department of Energy, which was intended to finance hydrogen production facilities [5]. - The company provides hydrogen fuel cell solutions and develops infrastructure for hydrogen production [5]. Group 3: Stock Performance and Impact - Plug Power's stock dropped 6.3% on October 7, 2025, following the abrupt departure of its CEO and President, falling from $4.13 to $3.87 per share [6]. - On November 10, 2025, the stock fell 3.4% after the company announced the suspension of activities under the DOE loan program, dropping from $2.65 to $2.56 per share [7]. - A further decline of 17.6% occurred on November 14, 2025, after reports confirmed the suspension of plans to construct hydrogen production facilities, with the stock price dropping from $2.49 to $2.25 per share [8].

Core Viewpoint - A class action lawsuit has been filed against Eos Energy Enterprises, Inc. for securities fraud following a significant stock drop of approximately 39% [1][6]. Group 1: Lawsuit Details - Investors have until May 5, 2026, to request to lead the case in the U.S. District Court for the District of New Jersey, under the caption Yung v. Eos Energy Enterprises, Inc., et al. [3] - The lawsuit alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of Eos Energy investors [3]. Group 2: Company Background - Eos Energy manufactures zinc-based long-duration battery energy storage systems aimed at storing renewable power and enhancing grid reliability [4]. - The company had previously projected revenue guidance of $150 million to $160 million for fiscal year 2025, citing manufacturing progress due to automation [4]. Group 3: Allegations and Stock Performance - The lawsuit claims that Eos Energy's statements regarding manufacturing progress and revenue guidance were materially false and misleading due to significant production inefficiencies and delays [5]. - On February 26, 2026, Eos reported a net loss of approximately $970 million for fiscal year 2025 and disclosed revenues that fell short of guidance, leading to a stock price decline of $4.39 per share, or about 39.4%, closing at $6.74 [6][7].

Core Viewpoint - Tennant Company is under investigation for possible securities fraud following a significant drop in stock price after disappointing financial results for 2025 [1][2]. Financial Performance - Tennant reported $291.6 million in revenue for the full year 2025, missing consensus estimates by $28.85 million [2]. - The company's earnings per share (EPS) was $0.48, falling short of estimates by $1.22 [2]. - Following the financial results announcement, Tennant's stock price fell by $19.28, or 23.4%, closing at $63.02 per share on February 24, 2026 [2]. Operational Challenges - The poor financial performance was attributed to the implementation of a new enterprise resource planning (ERP) system, which introduced unexpected challenges [2]. - Specific logistical issues included manufacturing scheduling problems, prolonged customer delays, and disruptions in order management and fulfillment [2].

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud or unlawful business practices involving ePlus, inc. following disappointing financial results that led to a significant drop in stock price [2][3]. Group 1: Company Performance - ePlus reported its financial results for Q3 2025 on February 5, 2025, which did not meet consensus estimates, attributing the shortfall to "digestion" in the networking space and select enterprise customers [2]. - Management indicated that the observed soft demand was primarily due to supply chain issues, highlighting external logistical factors as significant contributors to the underperformance [2]. Group 2: Stock Market Reaction - Following the announcement of the disappointing financial results, ePlus's stock price fell by $10.64 per share, representing a 13.1% decline, closing at $70.29 per share on February 6, 2025 [3]. Group 3: Legal Investigation - Pomerantz LLP is actively investigating claims on behalf of ePlus investors, suggesting potential legal action related to the company's financial disclosures and business practices [1][2].

Core Viewpoint - A class action lawsuit has been filed against Super Micro Computer, Inc. for alleged securities fraud and unlawful business practices related to the diversion of servers to China, violating U.S. export control laws [2]. Group 1: Class Action Lawsuit - Investors who suffered losses in Super Micro securities are encouraged to contact Pomerantz LLP to join the class action lawsuit [1]. - The deadline to apply as Lead Plaintiff in the class action is May 26, 2026, for those who purchased Super Micro securities during the Class Period [2]. Group 2: Allegations and Indictments - The U.S. Department of Justice announced an indictment against three individuals associated with Super Micro for a scheme to divert servers containing U.S. AI technology to China, which generated approximately $2.5 billion in sales from 2024 to 2025 [2]. - The individuals indicted include Yih-Shyan Liaw, Ruei-Tsang Chang, and Ting-Wei Sun, who allegedly conspired to divert servers without the necessary licenses [2]. Group 3: Market Reaction - Following the DOJ announcement, Super Micro's stock price dropped by $10.26, or 33.32%, closing at $20.54 per share on March 20, 2026 [3].

Core Viewpoint - Pomerantz LLP is investigating claims on behalf of investors of On Holding AG regarding potential securities fraud or unlawful business practices following the announcement of CEO Martin Hoffmann's planned departure [2]. Group 1: Company Developments - On Holding AG announced that Martin Hoffmann will step down as CEO in May 2026 to pursue philanthropic interests, with co-founders David Allemann and Caspar Coppetti set to serve as co-CEOs [2]. - This leadership change follows the departure of previous CEO Marc Maurer just one year earlier [2]. Group 2: Market Reaction - Following the announcement of the CEO's departure, On's stock price fell by $4.43 per share, representing an 11.19% decrease, closing at $36.16 per share on March 25, 2026 [3].

Core Viewpoint - The ImmunityBio class action lawsuit alleges that the company and its Executive Chairman made misleading statements regarding the efficacy of its lead product, Anktiva, leading to significant stock price declines following regulatory scrutiny [1][3][4]. Group 1: Lawsuit Details - The class action lawsuit seeks to represent purchasers of ImmunityBio securities from January 19, 2026, to March 24, 2026 [1]. - The lawsuit is titled Douglas v. ImmunityBio, Inc., and is filed in the Central District of California [1]. - Allegations include false claims about Anktiva's ability to cure cancer and misleading representations regarding its classification as a cancer vaccine [3]. Group 2: Regulatory Issues - A warning letter from the U.S. Food and Drug Administration (FDA) was issued to ImmunityBio's CEO, indicating that promotional materials misbranded Anktiva and violated federal regulations [4]. - The FDA's letter raised public health concerns, stating that the communications created a misleading impression about Anktiva's capabilities [4]. - Following the public disclosure of the FDA warning, ImmunityBio's stock price dropped by 21% [4]. Group 3: Company Background - ImmunityBio is a biotechnology company focused on developing next-generation immunotherapies, with Anktiva as its lead biologics product [2]. - The company is facing scrutiny due to the allegations of overstating the capabilities of Anktiva by its Executive Chairman and Global Scientific and Medical Officer [3].

Core Viewpoint - A class action lawsuit has been filed against Power Solutions International Inc. for allegedly misleading investors regarding its sales demand and manufacturing capacity in the data center market [1][4]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased Power Solutions securities from May 8, 2025, to March 2, 2026, alleging that the company overstated its sales capabilities and understated manufacturing inefficiencies [4]. - The company reported a gross margin of 23.9% for Q3 2025, a decrease of 5.0% year-over-year, attributed to production inefficiencies [4]. - Following the Q3 2025 results, Power Solutions' share price fell by $15.55, or approximately 19.1%, from $81.24 to $65.69 [4]. Group 2: Financial Performance - On March 2, 2026, Power Solutions announced a gross margin decline of 8% year-over-year due to operating inefficiencies, with only moderate margin improvement expected for 2026 [5]. - The share price dropped by $24.84, or approximately 29%, from $85.75 to $60.91 after the announcement of Q4 and full year 2025 results [5].